Inflammatory Biomarkers in Disease Prognosis

This cluster of papers explores the intricate relationship between inflammation and cancer, focusing on the role of immunity, systemic inflammatory response, platelets, and various prognostic markers in cancer development, progression, and treatment effectiveness. It delves into the mechanisms of inflammation-induced cancer, the impact of platelets on metastasis, and the potential of inflammatory pathways as therapeutic targets.